rs2075291

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001371904.1(APOA5):​c.553G>T​(p.Gly185Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,612,572 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G185D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0034 ( 13 hom., cov: 34)
Exomes 𝑓: 0.0029 ( 129 hom. )

Consequence

APOA5
NM_001371904.1 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4O:1

Conservation

PhyloP100: 0.159

Publications

184 publications found
Variant links:
Genes affected
APOA5 (HGNC:17288): (apolipoprotein A5) The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009]
APOA5 Gene-Disease associations (from GenCC):
  • hypertriglyceridemia 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hyperlipoproteinemia type V
    Inheritance: AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056571066).
BP6
Variant 11-116790676-C-A is Benign according to our data. Variant chr11-116790676-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 4402.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0605 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOA5NM_001371904.1 linkc.553G>T p.Gly185Cys missense_variant Exon 3 of 3 ENST00000227665.9 NP_001358833.1
APOA5NM_001166598.2 linkc.553G>T p.Gly185Cys missense_variant Exon 4 of 4 NP_001160070.1
APOA5NM_052968.5 linkc.553G>T p.Gly185Cys missense_variant Exon 4 of 4 NP_443200.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOA5ENST00000227665.9 linkc.553G>T p.Gly185Cys missense_variant Exon 3 of 3 1 NM_001371904.1 ENSP00000227665.4
APOA5ENST00000433069.2 linkc.553G>T p.Gly185Cys missense_variant Exon 4 of 4 1 ENSP00000399701.2
APOA5ENST00000673688.1 linkc.637G>T p.Gly213Cys missense_variant Exon 3 of 3 ENSP00000501141.1
APOA5ENST00000542499.5 linkc.553G>T p.Gly185Cys missense_variant Exon 4 of 4 5 ENSP00000445002.1

Frequencies

GnomAD3 genomes
AF:
0.00342
AC:
521
AN:
152192
Hom.:
13
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0661
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00637
AC:
1578
AN:
247782
AF XY:
0.00627
show subpopulations
Gnomad AFR exome
AF:
0.00252
Gnomad AMR exome
AF:
0.000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0667
Gnomad FIN exome
AF:
0.000332
Gnomad NFE exome
AF:
0.000332
Gnomad OTH exome
AF:
0.00231
GnomAD4 exome
AF:
0.00286
AC:
4182
AN:
1460262
Hom.:
129
Cov.:
34
AF XY:
0.00314
AC XY:
2284
AN XY:
726492
show subpopulations
African (AFR)
AF:
0.00215
AC:
72
AN:
33474
American (AMR)
AF:
0.000335
AC:
15
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.0712
AC:
2825
AN:
39692
South Asian (SAS)
AF:
0.00902
AC:
778
AN:
86238
European-Finnish (FIN)
AF:
0.000327
AC:
17
AN:
52054
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
0.000233
AC:
259
AN:
1111848
Other (OTH)
AF:
0.00335
AC:
202
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
323
646
969
1292
1615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00341
AC:
520
AN:
152310
Hom.:
13
Cov.:
34
AF XY:
0.00431
AC XY:
321
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41578
American (AMR)
AF:
0.000457
AC:
7
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0663
AC:
342
AN:
5162
South Asian (SAS)
AF:
0.0106
AC:
51
AN:
4828
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68016
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
24
48
71
95
119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00207
Hom.:
22
Bravo
AF:
0.00364
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.000582
AC:
5
ExAC
AF:
0.00613
AC:
744
Asia WGS
AF:
0.0280
AC:
98
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypertriglyceridemia 1 Uncertain:1Other:1
Oct 01, 2003
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27813673, 31901151, 31619059, 30132804, 30420299, 29263402, 28548292, 27516387, 26079787, 26690388, 25843152, 12915450, 21423763, 20134407, 25487149, 22008704, 25127531, 18635818) -

not specified Benign:1
Mar 05, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: APOA5 c.553G>T (p.Gly185Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0064 in 248436 control chromosomes, predominantly at a frequency of 0.067 within the East Asian subpopulation in the gnomAD database, including 54 homozygotes. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 1005 fold of the estimated maximal expected allele frequency for a pathogenic variant in APOA5 causing Hypertriglyceridemia phenotype (6.7e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. The following publications have been ascertained in the context of this evaluation (PMID: 18635818, 25127531, 20657596). ClinVar contains an entry for this variant (Variation ID: 4402). Based on the evidence outlined above, the variant was classified as likely benign. -

Cardiovascular phenotype Benign:1
May 24, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.53
D;D
Eigen
Benign
0.011
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.73
.;T
MetaRNN
Benign
0.0057
T;T
MetaSVM
Benign
-0.63
T
MutationAssessor
Uncertain
2.4
M;M
PhyloP100
0.16
PrimateAI
Benign
0.31
T
PROVEAN
Uncertain
-3.4
D;D
REVEL
Benign
0.28
Sift
Uncertain
0.021
D;D
Sift4G
Uncertain
0.010
D;D
Polyphen
1.0
D;D
Vest4
0.33
MVP
0.91
MPC
1.4
ClinPred
0.019
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.40
gMVP
0.49
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075291; hg19: chr11-116661392; COSMIC: COSV57062337; COSMIC: COSV57062337; API